FibroGen, Inc. (FGEN)

R&D Expense Growth

-75.42%

Fiscal year · Period ending:

FGEN logo

FGEN R&D Expense Growth

Latest reported-75.42%
FGEN FY R&D Growth (YoY) (0.00% → -75.42%)
High-resolution chart · PNG

FGEN r&d expense growth history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

FibroGen, Inc. R&D Expense Growth — Annual fiscal periods
Period endingR&D Expense Growth
-75.4243%
-64.0894%
-10.2153%
-23.3183%
53.0274%
20.863%
-11.2679%
20.0095%
4.9737%
-12.5569%
41.9745%
75.9351%
15.4779%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.